Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.

Pharmacologic Treatment of Low Bone Density or Osteoporosis to Prevent Fractures: A Clinical Practice Guideline from the American College of Physicians

Qaseem, Amir, Snow, Vincenza, Shekelle, Paul, Hopkins, Robert, Forciea, Mary Ann, Owens, Douglas K., Clinical Efficacy Assessment Subcommittee of the American College of Physicians · 2008 · Annals of Internal Medicine

Abstract

DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the available evidence on various pharmacologic treatments to prevent fractures in men and women with low bone density or osteoporosis. METHODS: Published literature on this topic was identified by using MEDLINE (1966 to December 2006), the ACP Journal Club database, the Cochrane Central Register of Controlled Trials (no date limits), the Cochrane Database of Systematic Reviews (no date limits), Web sites of the United Kingdom National Institute of Health and Clinical Excellence (no date limits), and the United Kingdom Health Technology Assessment Program (January 1998 to December 2006). Searches were limited to English-language publications and human studies. Keywords for search included terms for osteoporosis, osteopenia, low bone density, and the drugs listed in the key questions. This guideline grades the evidence and recommendations according to the ACP's clinical practice guidelines grading system. RECOMMENDATION 1: ACP recommends that clinicians offer pharmacologic treatment to men and women who have known osteoporosis and to those who have experienced fragility fractures (Grade: strong recommendation; high-quality evidence). RECOMMENDATION 2: ACP recommends that clinicians consider pharmacologic treatment for men and women who are at risk for developing osteoporosis (Grade: weak recommendation; moderate-quality evidence). RECOMMENDATION 3: ACP recommends that clinicians choose among pharmacologic treatment options for osteoporosis in men and women on the basis of an assessment of risk and benefits in individual patients (Grade: strong recommendation; moderate-quality evidence). RECOMMENDATION 4: ACP recommends further research to evaluate treatment of osteoporosis in men and women.

Overview

Integrity signals

Registry

Crossref · 10.7326/0003-4819-149-6-200809160-00007

Cites

151 of 151 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

9 retracted

Show all 151 references

Research works printed but not linked: 22

  1. Avenell A, 2005, Cochrane Database Syst Rev, CD000227
  2. Cranney A, 2000, Cochrane Database Syst Rev, CD001983
  3. Cranney A, 2006, Cochrane Database Syst Rev, CD003376
  4. Palmer S, 2005, Cochrane Database Syst Rev, CD005015
  5. Bone HG, 2000, J Clin Endocrinol Metab, 85, 720
  6. Homik J, 2000, Cochrane Database Syst Rev, CD001347
  7. Sato S, 2003, J Rheumatol, 30, 2673
  8. Reid IR, 1994, J Clin Endocrinol Metab, 79, 1595
  9. 10.1016/j.amjmed.2004.05.019 · DOI
  10. 10.1016/j.bone.2004.09.003 · DOI
  11. Homik JE, 1999, J Rheumatol, 26, 1148
  12. 10.1007/s00198-004-1713-3 · DOI · Paper page
  13. 10.1093/jnci/90.18.1371 · DOI · Paper page
  14. Muscoso E, 2004, Eur Rev Med Pharmacol Sci, 8, 97
  15. Blair MM, 2000, J Fam Pract, 49, 839
  16. 10.1002/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO;2-W · doi:10.1002/1529-0131(200101)44:1<202::aid-anr27>3.0.co;2-w
  17. Cortet B, 1999, Rev Rhum Engl Ed, 66, 214
  18. Geusens P, 1997, Bone, 20, 9S
  19. Meunier PJ, 1997, J Clin Endocrinol Metab, 82, 2784
  20. Silberstein EB, 1992, J Nucl Med, 33, 1
  21. Zheng S, 2003, Chin Med J (Engl), 116, 1127
  22. 10.1210/jcem.87.3.8325 · doi:10.1210/jcem.87.3.8325 · Paper page

Cited by

See all 180

Metadata

Authors
Qaseem, A., Snow, V., Shekelle, P., Hopkins, R., Forciea, M. A., Owens, D. K., & Clinical Efficacy Assessment Subcommittee of the American College of Physicians
Affiliations
University of Arkansas at Little Rock (US)
Venue
Annals of Internal Medicine
Published
2008-09-16
Volume
149
Issue
6
Pages
404-415
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2128498016
Cited by
180
References
151
Citations by year
2026: 2 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 6 · 2019: 8 · 2018: 3 · 2017: 11 · 2016: 7 · 2015: 9 · 2014: 9 · 2013: 17 · 2012: 14
FWCI
25.07
Type
journal article
Language
en
Open access
closed
Licence
www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Health Sciences › Medicine › Oncology › Bone health and treatments
Keywords
osteoporosis, osteopenia, fracture prevention, fragility fractures, pharmacotherapy, bisphosphonates, men, women, risk-benefit assessment
MeSH terms
Bone Diseases, Metabolic, Female, Humans, Male, Osteoporosis, Risk Factors, United States, Bone Density Conservation Agents, Fractures, Bone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacologic Treatment of Low Bone Density or Osteoporosis to Prevent Fractures: A Clinical Practice Guideline from the American College of Physicians. https://app.cochat.ai/papers/10.7326/0003-4819-149-6-200809160-00007
The paper
Qaseem, A., Snow, V., Shekelle, P., Hopkins, R., Forciea, M. A., Owens, D. K., & Clinical Efficacy Assessment Subcommittee of the American College of Physicians. (2008). Pharmacologic Treatment of Low Bone Density or Osteoporosis to Prevent Fractures: A Clinical Practice Guideline from the American College of Physicians. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-149-6-200809160-00007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.